PUNE, India, March 14, 2016 /PRNewswire/ --
North America is expected to hold the largest next generation sequencing market share in 2016 with global next generation sequencing (NGS) industry expected to reach $ 10,371.1 million by 2021 at a CAGR of 20.8% between 2016 and 2021.
Complete report on next generation sequencing (NGS) market spread across 264 pages, profiling 10 companies and supported with 232 tables and 57 figures is now available at http://www.reportsnreports.com/reports/153554-next-generation-sequencing-ngs-market-by-technology-pyrosequencing-others-competitors-illumina-454-roche-life-science-technologies-applications-tools-global-trends-forecasts-2011-2016-.html .
The NGS market is broadly segmented into products & services, technology, application, and end user. By products & services, the next generation sequencing (NGS) market is segmented into pre-sequencing products & services, NGS platforms, consumables, sequencing services, data analysis/bioinformatics. The consumables segment is expected to command the major share of the next generation sequencing (NGS) market, by products & services, in 2016.
Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global next generation sequencing (NGS) market in 2016, followed by Europe. Asia-Pacific NGS market is poised to witness highest growth rate during the forecast period from 2016 to 2021 due to a number of factors including improving healthcare infrastructure and favorable government initiatives.
Market growth is majorly driven by the technological advancements in next generation sequencing (NGS) products, increasing applications of NGS, entry of new market players, increasing partnerships & collaborations among market players, and growing incidences of cancer, inherited rare disorders, and pre- and neo-natal disorders.
As of 2015, the global NGS market was dominated by Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.); and Pacific Biosciences of California, Inc. (U.S.) which together held a share of 94% of the overall next generation sequencing (NGS) platforms market. New product launches & product enhancements; agreements, collaborations, & partnerships, geographic expansions; strategic acquisitions; and others (offering research fund & grants and organizing conferences/seminars) are the major strategies adopted by most market players to achieve growth in the global next generation sequencing (NGS) market.
The key players in the global next generation sequencing market are Illumina, Inc. (U.S.); Thermo Fisher Scientific, Inc. (U.S.); Pacific Biosciences of California, Inc. (U.S.); Roche Holding AG (Switzerland); QIAGEN N. V. (Germany); BGI (China), Macrogen Inc. (South Korea); Eurofins Scientific (Luxembourg); and Oxford Nanopore Technologies, Ltd. (U.K.). Order a copy of Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021 research report at http://www.reportsnreports.com/purchase.aspx?name=153554 .
From an insight perspective, this research report has focused on various levels of analysis -market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the next generation sequencing (NGS) market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.
On a related note, another research on North American Nuclear Medicine/Radiopharmaceuticals Market Forecasts to 2020 says, the market is projected to reach USD 2.98 Billion by 2020, growing at a CAGR of 8.6% during the forecast period of 2015 to 2020. The SPECT segment is expected to account for the largest share of the North American diagnostic nuclear medicine/radiopharmaceuticals market. Companies like Cardinal Health, Inc., Mallinckrodt PLC, GE Healthcare, Lantheus Medical Imaging, Inc., Bayer Healthcare, Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications S.A. and IBA Molecular Imaging have been profiled in this 180 pages research report at http://www.reportsnreports.com/reports/236047-north-american-nuclear-medicine-radiopharmaceuticals-stable-isotopes-market-spect-pet-radioisotopes-technetium-f-18-beta-alpha-radiation-therapy-i131-y-90-applications-cancer-oncology-cardiac-deuterium-c-13-forecast-to-2017.html .
Explore more reports on Biotechnology market at http://www.reportsnreports.com/market-research/biotechnology/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
+ 1 888 391 5441